183 related articles for article (PubMed ID: 24063837)
21. The association between admission systolic blood pressure of heart failure patients with preserved systolic function and mortality outcomes.
Rosman Y; Kopel E; Shlomai G; Goldenberg I; Grossman E
Eur J Intern Med; 2015 Dec; 26(10):807-12. PubMed ID: 26525208
[TBL] [Abstract][Full Text] [Related]
22. Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients.
Solomon SD; Anavekar N; Skali H; McMurray JJ; Swedberg K; Yusuf S; Granger CB; Michelson EL; Wang D; Pocock S; Pfeffer MA;
Circulation; 2005 Dec; 112(24):3738-44. PubMed ID: 16330684
[TBL] [Abstract][Full Text] [Related]
23. Predictors of mortality in patients hospitalized for congestive heart failure with left ventricular ejection fraction ≥ 40.
Sherazi S; McNitt S; Choudhary N; Shah AH; Aktas MK; Asgher A; Schwarz KQ; Zareba W
Cardiol J; 2015; 22(4):382-90. PubMed ID: 25588532
[TBL] [Abstract][Full Text] [Related]
24. Serum aldosterone is associated with mortality and re-hospitalization in patients with reduced ejection fraction hospitalized for acute heart failure: analysis from the EVEREST trial.
Girerd N; Pang PS; Swedberg K; Fought A; Kwasny MJ; Subacius H; Konstam MA; Maggioni A; Gheorghiade M; Zannad F;
Eur J Heart Fail; 2013 Nov; 15(11):1228-35. PubMed ID: 23787720
[TBL] [Abstract][Full Text] [Related]
25. Functional mitral regurgitation at discharge and outcomes in patients hospitalized for acute decompensated heart failure with a preserved or reduced ejection fraction.
Kajimoto K; Sato N; Takano T;
Eur J Heart Fail; 2016 Aug; 18(8):1051-9. PubMed ID: 27212582
[TBL] [Abstract][Full Text] [Related]
26. Prescription of cardiovascular drugs in the French ODIN cohort of heart failure patients according to age and type of chronic heart failure.
Juillière Y; Suty-Selton C; Riant E; Darracq JP; Dellinger A; Labarre JP; Druelle J; Mulak G; Danchin N; Jourdain P;
Arch Cardiovasc Dis; 2014 Jan; 107(1):21-32. PubMed ID: 24388162
[TBL] [Abstract][Full Text] [Related]
27. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure.
Hillege HL; Nitsch D; Pfeffer MA; Swedberg K; McMurray JJ; Yusuf S; Granger CB; Michelson EL; Ostergren J; Cornel JH; de Zeeuw D; Pocock S; van Veldhuisen DJ;
Circulation; 2006 Feb; 113(5):671-8. PubMed ID: 16461840
[TBL] [Abstract][Full Text] [Related]
28. Poor prognosis in chronic heart failure patients with reduced ejection fraction in China.
Cheng Z; Zhu K; Chen T; Gao P; Cheng K; Fang L; Deng H; Zhu W; Fang Q
Congest Heart Fail; 2012; 18(3):165-72. PubMed ID: 22587746
[TBL] [Abstract][Full Text] [Related]
29. Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure: results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program.
O'Meara E; Clayton T; McEntegart MB; McMurray JJ; Piña IL; Granger CB; Ostergren J; Michelson EL; Solomon SD; Pocock S; Yusuf S; Swedberg K; Pfeffer MA;
Circulation; 2007 Jun; 115(24):3111-20. PubMed ID: 17562950
[TBL] [Abstract][Full Text] [Related]
30. Uptitration of renin-angiotensin system blocker and beta-blocker therapy in patients hospitalized for heart failure with reduced versus preserved left ventricular ejection fractions.
Verbrugge FH; Duchenne J; Bertrand PB; Dupont M; Tang WH; Mullens W
Am J Cardiol; 2013 Dec; 112(12):1913-20. PubMed ID: 24286620
[TBL] [Abstract][Full Text] [Related]
31. Global Longitudinal Strain to Predict Mortality in Patients With Acute Heart Failure.
Park JJ; Park JB; Park JH; Cho GY
J Am Coll Cardiol; 2018 May; 71(18):1947-1957. PubMed ID: 29724346
[TBL] [Abstract][Full Text] [Related]
32. Clinical and prognostic effects of atrial fibrillation in heart failure patients with reduced and preserved left ventricular ejection fraction.
Linssen GC; Rienstra M; Jaarsma T; Voors AA; van Gelder IC; Hillege HL; van Veldhuisen DJ
Eur J Heart Fail; 2011 Oct; 13(10):1111-20. PubMed ID: 21642293
[TBL] [Abstract][Full Text] [Related]
33. Risk stratification of mortality in patients with heart failure and left ventricular ejection fraction >35%.
Cygankiewicz I; Zareba W; Vazquez R; Bayes-Genis A; Pascual D; Macaya C; Almendral J; Fiol M; Bardaji A; Gonzalez-Juanatey JR; Nieto V; Valdes M; Cinca J; de Luna AB;
Am J Cardiol; 2009 Apr; 103(7):1003-10. PubMed ID: 19327431
[TBL] [Abstract][Full Text] [Related]
34. [Comparative study on characteristics of congestive heart failure patients with preserved versus abnormal left ventricular systolic function and evaluation effects of therapy].
Zhan H; Tse HF; Cao JM; Lau CP
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2006 Apr; 18(4):210-5. PubMed ID: 16647010
[TBL] [Abstract][Full Text] [Related]
35. B-type natriuretic peptide can predict the medium-term risk in patients with acute heart failure and preserved systolic function.
Valle R; Aspromonte N; Feola M; Milli M; Canali C; Giovinazzo P; Carbonieri E; Ceci V; Cerisano S; Barro S; Milani L
J Card Fail; 2005 Sep; 11(7):498-503. PubMed ID: 16198244
[TBL] [Abstract][Full Text] [Related]
36. Independence of restrictive filling pattern and LV ejection fraction with mortality in heart failure: an individual patient meta-analysis.
; Doughty RN; Klein AL; Poppe KK; Gamble GD; Dini FL; Møller JE; Quintana M; Yu CM; Whalley GA
Eur J Heart Fail; 2008 Aug; 10(8):786-92. PubMed ID: 18617438
[TBL] [Abstract][Full Text] [Related]
37. Gender does not affect postdischarge outcomes in patients hospitalized for worsening heart failure with reduced ejection fraction (from the Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan [EVEREST] Trial).
Shah AN; Mentz RJ; Gheorghiade M; Kwasny MJ; Fought AJ; Zannad F; Swedberg K; Maggioni AP; Konstam MA
Am J Cardiol; 2012 Dec; 110(12):1803-8. PubMed ID: 22999071
[TBL] [Abstract][Full Text] [Related]
38. Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study.
Hsu JC; Solomon SD; Bourgoun M; McNitt S; Goldenberg I; Klein H; Moss AJ; Foster E;
J Am Coll Cardiol; 2012 Jun; 59(25):2366-73. PubMed ID: 22698490
[TBL] [Abstract][Full Text] [Related]
39. Prevalence and prognostic impact of bundle branch block in patients with heart failure: evidence from the CHARM programme.
Hawkins NM; Wang D; McMurray JJ; Pfeffer MA; Swedberg K; Granger CB; Yusuf S; Pocock SJ; Ostergren J; Michelson EL; Dunn FG;
Eur J Heart Fail; 2007 May; 9(5):510-7. PubMed ID: 17317308
[TBL] [Abstract][Full Text] [Related]
40. Clinical characteristics and prognosis of patients admitted for heart failure: A 5-year retrospective study of African patients.
Bonsu KO; Owusu IK; Buabeng KO; Reidpath DD; Kadirvelu A
Int J Cardiol; 2017 Jul; 238():128-135. PubMed ID: 28318656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
